SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q1 2026 Earnings Call Transcript
Operator: Good morning. My name is Vincent, and I'll be your conference operator today.
Sophia Genetics Sa (SOPH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Generation Investment Management David Blood And Al Gore | 6,789,560 | $33,608,322 | 0.3% | |
| 2. | Akre Capital Management Charles Akre | 3,719,140 | $18,409,743 | 0.3% | |
| 3. | Soleus Capital Guy Levy | 1,850,000 | $9,157,500 | 0.37% | |
| 4. | Royce & Associates Chuck Royce | 1,816,312 | $8,990,744 | +323% | 0.09% |
| 5. | Archon Capital Management Constantinos J. Christofilis | 441,413 | $2,184,994 | 1.23% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.60 | 761 | $3,501.06 | 680,911 | 2026-05-19 | Filing | |
| $4.60 | 608 | $2,797.71 | 626,280 | 2026-05-19 | Filing | |
| $4.60 | 4,486 | $20,657.58 | 3,629,495 | 2026-05-19 | Filing | |
| $4.61 | 608 | $2,800.39 | 255,780 | 2026-05-19 | Filing | |
| $4.60 | 684 | $3,149.27 | 345,052 | 2026-05-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,208,280 | $10,930,986 | 0.08% | |
| 2. | 1,409,242 | $6,975,748 | 0% | |
| 3. | 1,409,160 | $6,975,342 | 2.27% | |
| 4. | 927,800 | $4,592,610 | 0.1% | |
| 5. | 692,809 | $3,429,405 | 0.54% |
News See All
8 Best Healthcare AI Stocks to Buy According to Analysts
Healthcare AI stocks are getting more attention as investors look for places where artificial intelligence can move beyond chatbots and productivity tools into real-world markets.
SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q4 2025 Earnings Call Transcript
Operator: Good morning. My name is Angeline, and I will be your conference operator today. At this time, I would like to welcome everyone to the SOPHiA GENETICS S.A.
SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q3 2025 Earnings Call Transcript
Operator: Good morning. My name is Kelsey, and I'll be your conference operator today.
SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q2 2025 Earnings Call Transcript
Operator: Good morning. My name is Danny, and I'll be your conference operator today.
SOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the SOPHiA GENETICS Q1 2025 Earnings Call. [Operator Instructions]. This call is being recorded on Tuesday, May 6, 2025.
SOPHiA GENETICS SA (NASDAQ:SOPH) Q4 2024 Earnings Call Transcript
Operator: Good morning. My name is Liway, and I'll be your conference operator today.
SOPHiA GENETICS SA (NASDAQ:SOPH) Q3 2024 Earnings Call Transcript
Operator: Good morning. My name is Nicole [ph] and I will be your conference operator today.
SOPHiA GENETICS SA (SOPH): A Bull Case Theory
We came across a bullish thesis on SOPHiA GENETICS SA (SOPH) on Two Natural Cap’s Substack by Two Natural Capital. In this article, we will summarize the bulls’ thesis on SOPH.
SOPHiA GENETICS SA (NASDAQ:SOPH) Q2 2024 Earnings Call Transcript
Operator: Good morning. My name is Kevin and I'll be your conference operator for today. At this time, I'd like to welcome everyone to the SOPHiA GENETICS Second Quarter 2024 Earnings Conference Call.
Hedge Fund Resource Center